Clinical guideline for the diagnosis and treatment of fibrolamellar carcinoma.

In brief

This clinical guideline provides evidence-based recommendations for diagnosing and managing fibrolamellar carcinoma, a rare primary liver malignancy that predominantly affects adolescents and young adults without underlying liver disease. The guideline addresses diagnostic imaging, pathologic confirmation, surgical resection strategies, and surveillance protocols for this distinct hepatocellular tumor variant.

Written by the GCMD Library team from the article.